InMed Pharmaceuticals Inc.INMNASDAQ
Loading
Price to Sales: Premium ValuationElevated
Percentile Rank93
3Y CAGR+38.5%
Studio
Year-over-Year Change

Price-to-sales ratio

3Y CAGR
+38.5%/yr
Annual compound
Percentile
P93
Near historical high
vs 3Y Ago
2.7x
Strong expansion
Streak
1 yr
Consecutive growthElevated
PeriodValueYoY Change
20250.64+53.9%
20240.42-24.0%
20230.55+127.0%
20220.24-
20210.00-
20200.00-
20190.00-
20180.00-
20170.00-
20160.00-